BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24841412)

  • 1. Silencing histone deacetylase 2 using small hairpin RNA induces regression of fibrotic plaque in a rat model of Peyronie's disease.
    Kwon KD; Choi MJ; Park JM; Song KM; Kwon MH; Batbold D; Yin GN; Kim WJ; Ryu JK; Suh JK
    BJU Int; 2014 Dec; 114(6):926-36. PubMed ID: 24841412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of histone deacetylase 2 mitigates profibrotic TGF-β1 responses in fibroblasts derived from Peyronie's plaque.
    Ryu JK; Kim WJ; Choi MJ; Park JM; Song KM; Kwon MH; Das ND; Kwon KD; Batbold D; Yin GN; Suh JK
    Asian J Androl; 2013 Sep; 15(5):640-5. PubMed ID: 23770939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing Histone Deacetylase 7 Alleviates Transforming Growth Factor-β1-Induced Profibrotic Responses in Fibroblasts Derived from Peyronie's Plaque.
    Kang DH; Yin GN; Choi MJ; Song KM; Ghatak K; Minh NN; Kwon MH; Seong DH; Ryu JK; Suh JK
    World J Mens Health; 2018 May; 36(2):139-146. PubMed ID: 29706035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IN-1130, a novel transforming growth factor-beta type I receptor kinase (activin receptor-like kinase 5) inhibitor, promotes regression of fibrotic plaque and corrects penile curvature in a rat model of Peyronie's disease.
    Ryu JK; Piao S; Shin HY; Choi MJ; Zhang LW; Jin HR; Kim WJ; Han JY; Hong SS; Park SH; Lee SJ; Kim IH; Lee CR; Kim DK; Mamura M; Kim SJ; Suh JK
    J Sex Med; 2009 May; 6(5):1284-96. PubMed ID: 19473283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated intratunical injection of adenovirus expressing transforming growth factor-beta1 in a rat induces penile curvature with tunical fibrotic plaque: a useful model for the study of Peyronie's disease.
    Piao S; Ryu JK; Shin HY; Zhang L; Song SU; Han JY; Park SH; Kim JM; Kim IH; Kim SJ; Suh JK
    Int J Androl; 2008 Jun; 31(3):346-53. PubMed ID: 17651407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in Peyronie's-like plaque size using a vacuum erection device in a rat model of Peyronie's disease via the TGF-β/SMAD signalling pathway.
    Li J; Wang S; Qin F; Zhu M; You X; Wu C; Fu F; Yuan J
    Andrologia; 2018 Sep; 50(7):e13051. PubMed ID: 29806152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor (TGF)-β type I receptor kinase (ALK5) inhibitor alleviates profibrotic TGF-β1 responses in fibroblasts derived from Peyronie's plaque.
    Piao S; Choi MJ; Tumurbaatar M; Kim WJ; Jin HR; Shin SH; Tuvshintur B; Yin GN; Song JS; Kwon MH; Lee SJ; Han JY; Kim SJ; Ryu JK; Suh JK
    J Sex Med; 2010 Oct; 7(10):3385-95. PubMed ID: 20233292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratunical injection of rat-derived bone marrow mesenchymal stem cells prevents fibrosis and is associated with increased Smad7 expression in a rat model of Peyronie's disease.
    Wang W; Ding W; Zhang X; Wu S; Yu T; Cui X; Xie Y; Yang D; Lin C
    Stem Cell Res Ther; 2022 Jul; 13(1):390. PubMed ID: 35908015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of SMAD7 gene overexpression on TGF-β1-induced profibrotic responses in fibroblasts derived from Peyronie's plaque.
    Choi MJ; Song KM; Park JM; Kwon MH; Kwon KD; Park SH; Ryu DS; Ryu JK; Suh JK
    Asian J Androl; 2015; 17(3):487-92. PubMed ID: 25532569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrin as an inducer of fibrosis in the tunica albuginea of the rat: a new animal model of Peyronie's disease.
    Davila HH; Ferrini MG; Rajfer J; Gonzalez-Cadavid NF
    BJU Int; 2003 Jun; 91(9):830-8. PubMed ID: 12780843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratunical Injection of Genetically Modified Adipose Tissue-Derived Stem Cells with Human Interferon α-2b for Treatment of Erectile Dysfunction in a Rat Model of Tunica Albugineal Fibrosis.
    Gokce A; Abd Elmageed ZY; Lasker GF; Bouljihad M; Braun SE; Kim H; Kadowitz PJ; Abdel-Mageed AB; Sikka SC; Hellstrom WJ
    J Sex Med; 2015 Jul; 12(7):1533-44. PubMed ID: 26062100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vactosertib, a Novel, Orally Bioavailable Activin Receptor-Like Kinase 5 Inhibitor, Promotes Regression of Fibrotic Plaques in a Rat Model of Peyronie's Disease.
    Song KM; Chung DY; Choi MJ; Ghatak K; Minh NN; Limanjaya A; Kwon MH; Ock J; Yin GN; Kim DK; Ryu JK; Suh JK
    World J Mens Health; 2020 Oct; 38(4):552-563. PubMed ID: 31496148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratunical injection of human urine-derived stem cells derived exosomes prevents fibrosis and improves erectile function in a rat model of Peyronie's disease.
    Yang Q; Chen W; Han D; Zhang C; Xie Y; Sun X; Liu G; Deng C
    Andrologia; 2020 Dec; 52(11):e13831. PubMed ID: 32986908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipose tissue-derived stem cell therapy for prevention and treatment of erectile dysfunction in a rat model of Peyronie's disease.
    Gokce A; Abd Elmageed ZY; Lasker GF; Bouljihad M; Kim H; Trost LW; Kadowitz PJ; Abdel-Mageed AB; Sikka SC; Hellstrom WJ
    Andrology; 2014 Mar; 2(2):244-51. PubMed ID: 24574095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of apoptotic gene expression profiles between Peyronie's disease plaque and tunica albuginea.
    Zorba OU; Sirma S; Ozgon G; Salabas E; Ozbek U; Kadioglu A
    Adv Clin Exp Med; 2012; 21(5):607-14. PubMed ID: 23356197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the Role of Adenosine Receptors in the Myofibroblast Transformation in Peyronie's Disease.
    Mateus M; Ilg MM; Stebbeds WJ; Christopher N; Muneer A; Ralph DJ; Cellek S
    J Sex Med; 2018 Jul; 15(7):947-957. PubMed ID: 29891411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profibrotic role of myostatin in Peyronie's disease.
    Cantini LP; Ferrini MG; Vernet D; Magee TR; Qian A; Gelfand RA; Rajfer J; Gonzalez-Cadavid NF
    J Sex Med; 2008 Jul; 5(7):1607-22. PubMed ID: 18422491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat model.
    Vernet D; Ferrini MG; Valente EG; Magee TR; Bou-Gharios G; Rajfer J; Gonzalez-Cadavid NF
    Nitric Oxide; 2002 Dec; 7(4):262-76. PubMed ID: 12446175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transcriptional signatures of cells from the human Peyronie's disease plaque and the ability of these cells to generate a plaque in a rat model suggest potential therapeutic targets.
    Gelfand RA; Vernet D; Kovanecz I; Rajfer J; Gonzalez-Cadavid NF
    J Sex Med; 2015 Feb; 12(2):313-27. PubMed ID: 25496134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression in Peyronie's disease.
    Gonzalez-Cadavid NF; Magee TR; Ferrini M; Qian A; Vernet D; Rajfer J
    Int J Impot Res; 2002 Oct; 14(5):361-74. PubMed ID: 12454687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.